Anker, S., Friede, T., Butler, J., Talha, K. M., Placzek, M., Diek, M., . . . Karakas, M. (2025). Ferric carboxymaltose assessment of morbidity and mortality in patients with iron deficiency and chronic heart failure (FAIR-HF2-DZHK05) trial: Baseline characteristics and comparison to other relevant clinical trials. European journal of heart failure, 27(8), . https://doi.org/10.1002/ejhf.3658
Chicago-Zitierstil (17. Ausg.)Anker, Stefan, et al. "Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure (FAIR-HF2-DZHK05) Trial: Baseline Characteristics and Comparison to Other Relevant Clinical Trials." European Journal of Heart Failure 27, no. 8 (2025). https://doi.org/10.1002/ejhf.3658.
MLA-Zitierstil (9. Ausg.)Anker, Stefan, et al. "Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure (FAIR-HF2-DZHK05) Trial: Baseline Characteristics and Comparison to Other Relevant Clinical Trials." European Journal of Heart Failure, vol. 27, no. 8, 2025, https://doi.org/10.1002/ejhf.3658.